arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Akebia Therapeutics, Inc.

AKBA

$0.91 ▼ -0.04 (-4.34%) at close

15 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bearish

auto_awesome

Analytical Summary

Akebia Therapeutics, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $234.0M

Dividend Yield —

Revenue Growth 47.5% ↗

Op. Margin 9.9% ↗

ROIC 41.7% ↘

FCF / Share $0.26 ↗

Trailing P/E —

Price / Book 7.4x

FCF Yield 28.9%

Debt / Equity 1.48

info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$236.20M

↑ +47.5% —

Net Income Profit after all expenses

$-5.34M

↑ +92.3% —

Operating Margin Operating profit as % of sales

9.9%

↑ +131.6% 56th

FCF / Share Free cash flow per share

$0.26

↑ +236.5% —

Long-Term Debt Long-term obligations

$48.25M

↑ +24.7% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue Growth YoY (%)	47.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+493%)	-17.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-321%)	-33.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-519%)	37.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+363%)	-27.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-446%)	-11.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-248%)	61.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+666%)	14.6% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+83%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	93.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-17.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	45.1% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	70.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	38.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	92.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-33.7% Weak ↓ Weak Declining Year-over-year change in net income	43.9% Excellent ↑ Excellent Improving Year-over-year change in net income	67.3% Excellent ↑ Excellent Improving Year-over-year change in net income	26.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-37.1% Weak ↑ Weak Improving Year-over-year change in net income	-94.8% Weak ↓ Weak Declining Year-over-year change in net income	-94.9% Weak ↓ Weak Declining Year-over-year change in net income	45.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-123.6% Weak ↓ Weak Declining Year-over-year change in net income	-63.9% Weak ↑ Weak Improving Year-over-year change in net income	-181.3% Weak Weak Year-over-year change in net income	-60.7% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	-54.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	68.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	73.7% Excellent Excellent Year-over-year change in free cash flow	-90.7% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-6.9% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-9.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-13.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-4.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	0.9% Weak Weak Compound annual revenue growth over 3 years	17.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-4.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-13.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-1.3% Weak Weak Compound annual revenue growth over 5 years	10.1% Good Good Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Operating Margin (%) (%)	9.9% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-34%)	-31.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-310%)	-23.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-258%)	-27.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-280%)	-124.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-928%)	-127.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-950%)	-85.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-670%)	-85.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-672%)	-42.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-382%)	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-43.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	16.5% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—
Profit Margin (%) (%)	-2.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-119%)	-43.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-461%)	-26.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-322%)	-31.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-364%)	-132.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1204%)	-129.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1182%)	-83.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-796%)	-69.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-676%)	-40.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-439%)	—	—	—	—	—	—
FCF Margin (%) (%)	28.7% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-25.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-12.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-25.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-118.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-37.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-78.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-47.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-31.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—
FCF / Net Income (x)	-12.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	41.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	380.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-891.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-104.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-152.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-109.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-59.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-49.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-158.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	9.9% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	11.3% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	6.2% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-22.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-50.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-58.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-45.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-46.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-16.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	141.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+841%)	169.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1032%)	—	—	-154.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1132%)	-70.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-572%)	-22.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-251%)	-60.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-501%)	-199.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1429%)	-46.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-409%)	-35.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-337%)	10.4% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-31%)	13.8% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-8%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Debt to Equity (x)	1.48x Caution ↓ Caution Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+147%)	-0.79x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-231%)	-1.13x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-289%)	7.07x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1079%)	1.28x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+113%)	0.39x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-35%)	0.19x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-68%)	—	—	—	—	—	—	—	—
Interest Coverage (x)	3.86x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	-10.02x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.63x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.71x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-27.55x Weak Weak Operating income divided by interest expense Optimal: > 5x	-48.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	-22.63x Weak Weak Operating income divided by interest expense Optimal: > 5x	-5.18x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-136.59M	$-13.18M	$-8.24M	$-24.39M	$-52.26M	$-132.32M	$-71.64M	$-104.64M	$-70.16M	$-187.34M	$-49.78M	$-32.78M	$-21.22M	$-1.64M	$-5.01M
Debt / EBITDA (x)	1.95x Good ↑ Good Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.79x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.78x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.85x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.37x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.26x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.27x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue per Share (USD)	$0.92	$0.76	$1.04	$1.60	$1.29	$2.13	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.02	$-0.33	$-0.28	$-0.51	$-1.70	$-2.77	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$0.26	$-0.19	$-0.12	$-0.40	$-1.52	$-0.80	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.12	$-0.22	$-0.16	$0.05	$0.43	$1.67	$3.24	$5.44	$2.57	$1.76	$4.27	$5.11	$-91.86	—	—
Tangible Book Value per Share (USD)	$-0.10	$-0.48	$-0.65	$-0.25	$0.12	$1.30	$2.79	$4.97	$2.57	$1.76	$4.27	$5.11	$-91.86	—	—
Basic Weighted Avg Shares (shares)	257.16M	210.95M	187.47M	182.78M	165.95M	138.46M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$90.02M	$32.92M	$18.28M	$60.19M	$15.52M	$184.29M	$101.42M	$202.58M	$217.25M	$182.05M	$129.15M	$103.59M	$29.53M	—	—
LT Debt (USD)	$48.25M	$38.69M	$34.68M	$66.08M	$97.54M	$96.38M	$75.81M	—	—	—	—	—	—	—	—
Total Equity (USD)	$32.61M	$-49.19M	$-30.58M	$9.34M	$76.46M	$247.62M	$394.76M	$635.93M	$122.57M	$68.12M	$131.00M	$104.08M	$-127.07M	$-59.59M	$-48.19M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	$236.20M	$160.18M	$194.62M	$292.60M	$213.58M	$295.31M	$335.00M	$207.74M	$181.23M	—	$0.00	$0.00	—	—	—
Depreciation Expense (USD)	$1.27M	$1.46M	$1.58M	$1.65M	$1.93M	$2.08M	$2.25M	$899.00K	$617.00K	$296.00K	$96.00K	$49.36K	$1.28K	$0.00	—
Net Income, GAAP (USD)	$-5.34M	$-69.41M	$-51.92M	$-92.56M	$-282.84M	$-383.46M	$-279.66M	$-143.59M	$-73.67M	$-135.75M	$-60.72M	$-37.03M	$-13.17M	$-8.20M	—
Operating Cash Flow (USD)	$67.99M	$-40.66M	$-23.38M	$-73.15M	$-252.97M	$-110.39M	$-257.44M	$-97.49M	$-56.16M	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 55 quarters

Akebia Therapeutics, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AKBA with peers